Book Details


New Vision of Metformin in treating cancer / George Al Maarawi ; Hamdan Mohamad ; Ghena Rmih ; Lidya Al Kazzaz

Publication year: 2019

ISBN: Ph00036

Internet Resource: Please Login to download book

The anti-diabetic drug metformin is rapidly emerging as a potential anticancer agent. Metformin is a biguanide that is effective in treating type 2 diabetes and the insulin resistance syndromes, improves insulin resistance by reducing hepatic gluconeogensis and by enhancing glucose uptake by skeletal muscle. Metformin can reduce the incidence of cancers and can reduce the mortality from cancers, increase the response to treatment cancer cells when using radiotherapy and chemotherapy, reduce the likelihood of relapse. Diabetes can be a factor in the occurrence of various types of cancer, and develop a variety of cancers such as colo-rectal, pancreas and liver cancers, compared to non-diabetic patients. Incidence of various cancers is high among patients of T2DM due to insulin resistance and mitogenic effects caused by hyperglycemia.

Subject: Metformin, Neoplasms, Tumors, Breast Cancer, Thyroid Cancer, Pancreatic Cancer